These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15752292)

  • 21. Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.
    Lecha M
    Br J Dermatol; 2001 Oct; 145 Suppl 60():21-6. PubMed ID: 11777261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous itraconazole treatment for onychomycosis and dermatomycosis: an overview of safety.
    Nolting SK; Gupta A; Doncker PD; Jacko ML; Moskovitz BL
    Eur J Dermatol; 1999; 9(7):540-3. PubMed ID: 10523732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of itraconazole pulse therapy for onychomycosis. An update.
    De Doncker P; Gupta AK; Cel Rosso JQ; Daniel CR; Rosen T; Verspeelt J; Marynissen G; Meuleneers L; Moskovitz B; Jacko M; Shear N; Odom RB; Aly R; Scher RK; Elewski BE
    Postgrad Med; 1999 Jul; Spec No():17-25. PubMed ID: 10492662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, randomized comparison of itraconazole capsules vs. placebo in the treatment of toenail onychomycosis.
    Elewski BE; Scher RK; Aly R; Daniel R; Jones HE; Odom RB; Zaias N; Jacko ML
    Cutis; 1997 Apr; 59(4):217-20. PubMed ID: 9104548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of onychomycosis due to Aspergillus sydowii diagnosed using DNA sequence analysis.
    Takahata Y; Hiruma M; Sugita T; Muto M
    Mycoses; 2008 Mar; 51(2):170-3. PubMed ID: 18254756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onychomycosis: a new emerging infectious disease in childhood population and adolescents. Report on treatment experience with terbinafine and itraconazole in 36 patients.
    Ginter-Hanselmayer G; Weger W; Smolle J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):470-5. PubMed ID: 18194238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onychomycosis caused by Fusarium sp in Sri Lanka: prevalence, clinical features and response to itraconazole pulse therapy in six cases.
    Ranawaka RR; de Silva N; Ragunathan RW
    J Dermatolog Treat; 2008; 19(5):308-12. PubMed ID: 19160539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?
    Shemer A; Nathansohn N; Kaplan B; Trau H
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):279-82. PubMed ID: 18269594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The treatment of extensive onychomycosis in aged patients].
    Maleszka R; Adamski Z
    Wiad Parazytol; 2001; 47(4):817-22. PubMed ID: 16886433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
    Degreef H; del Palacio A; Mygind S; Ginter G; Pinto Soares A; Zuluaga de Cadena A
    Acta Derm Venereol; 1999 May; 79(3):221-3. PubMed ID: 10384922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onychomycosis caused by Fusarium proliferatum.
    Hattori N; Shirai A; Sugiura Y; Li W; Yokoyama K; Misawa Y; Okuzumi K; Tamaki K
    Br J Dermatol; 2005 Sep; 153(3):647-9. PubMed ID: 16120158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails.
    Casciano J; Amaya K; Doyle J; Arikian S; Shear N; Haspel M; Kahler K
    Manag Care; 2003 Mar; 12(3):47-54. PubMed ID: 12685377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curing onychomycosis: understanding the multitude of variables.
    Lagana FJ
    Clin Podiatr Med Surg; 2004 Oct; 21(4):555-64, vi. PubMed ID: 15450896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Itraconazole for onychomycosis.
    Med Lett Drugs Ther; 1996 Jan; 38(966):5-6. PubMed ID: 8544793
    [No Abstract]   [Full Text] [Related]  

  • 35. Intermittent pulse therapy with itraconazole for onychomycosis. Experience in Hong Kong Chinese.
    Tang WY; Chong LY; Leung CY; Ho HH; Wong TW
    Mycoses; 2000; 43(1-2):35-9. PubMed ID: 10838844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Itraconazole concentrations of fingernails and toenails of patients with tinea unguium.
    Maeda M
    J Dermatol; 2008 May; 35(5):314-5. PubMed ID: 18477237
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral treatment of onychomycosis.
    Ellis MR; Kane KY
    J Fam Pract; 1999 Apr; 48(4):252. PubMed ID: 10229245
    [No Abstract]   [Full Text] [Related]  

  • 38. The safety of itraconazole in the diabetic population.
    Albreski DA; Gross EG
    J Am Podiatr Med Assoc; 1999 Jul; 89(7):339-45. PubMed ID: 10423939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
    De Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
    Chang CH; Young-Xu Y; Kurth T; Orav JE; Chan AK
    Am J Med; 2007 Sep; 120(9):791-8. PubMed ID: 17765049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.